GBUK Group, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired UK-based Severn Healthcare Technologies (“Severn”), a value-added and fast-growing distributor of single-use medical devices.
Founded in 2014, Severn specialises in providing next-generation single-use medical devices across the Ear, Nose, and Throat (“ENT”) and Neuro-Otology clinical specialisms. Supporting the adoption of clinical innovation in operating theatres across the National Health Service (“NHS”) and the UK Private market, Severn has built a reputation as a trusted partner to surgical clinicians on the foundations of deep technical expertise and exceeding customer service.
The acquisition of Severn represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s clinical specialist positioning further while expanding its product presence in two new and innovative therapeutic areas.
PMSI provided CDD to support the transaction, covering key investment themes such as: long-term growth drivers of the ENT consumables market; the impact of less invasive treatments on the neurotological market; the effect of COVID on NHS procedure backlogs, as well as Severn’s competitive positioning in the UK.
Article
PMSI supports Foresight Group's exit of ABL Health
Bolton-based private healthcare service provider ABL Health has been sold to Bay Tree Private Equity. ABL Health is commissioned by local authorities and the...